Reviewing the Latest Research on Value-Based Care, Clinical Pathways, and Precision Medicine

Multiple Myeloma, Lymphoma Respond Differently to Treatment for Anemia

A comparative effectiveness study analyzed response to anemia supportive treatment for patients with multiple myeloma or lymphoma.

Read More

 

Health Care Utilization High for Hospitalized Patients With Advanced Cancer

According to a recent study, symptom burden tends to be high among hospitalized patients with advanced cancer, which leads to increased use of health care resources.

Read More

 

Novel EGFR-TKI Superior to Conventional Therapies for NSCLC

The oral, third-generation, irreversible EGFR-TKI osimertinib is superior to standard EGFR-TKIs including gefitinib and erlotinib as a first-line treatment for EGFR mutation-positive advanced NSCLC.

Read More 

 

Burden of Sarcoma May Be Underestimated in National Cancer Database

Data from the National Cancer Database, which is heavily dependent on institutional reporting, could be misleading about the burden of sarcomas in the United States.

Read More

 

Novel Adjuvant Therapy Regimen Reduces Relapse in HER2-Positive Breast Cancer

A 5-year sensitivity analysis of a recent trial showed improved efficacy outcomes and toxicity profiles for patients receiving a new adjuvant therapy for HER2-positive breast cancer.

Read More

 

NCCN Updates Guidelines for Prevention, Treatment of Cancer-Related Infections

The National Comprehensive Cancer Network recently released updated guidelines for the treatment of cancer-related infections, fever, neutropenia, and other adverse events.

Read More

 

Blue Cross Blue Shield, Google Affiliate Partner for Diabetes Care Program

The Blue Cross Blue Shield Association has announced a partnership with a Google-affiliated company to provide personalized type 2 diabetes care to members of its health plans.

Read More

 

Many With Ovarian Cancer Choose Maintenance Therapy to Buy Time for Survival

A recent survey asked patients with primary and recurrent ovarian cancer to consider their reasons for choosing maintenance therapy following surgery and chemotherapy.

Read More



Select Page:     Next ->